•
Dec 31, 2011

Jazz Pharmaceuticals Q4 2011 Earnings Report

Total Revenue
$83.5M
Previous year: $53.4M
+56.5%
EPS
$0.89
Previous year: $0.88
+1.1%
Gross Profit
$79.7M
Previous year: $48.6M
+64.0%
Cash and Equivalents
$82.1M
Previous year: $44.8M
+83.2%
Total Assets
$254M
Previous year: $136M
+86.8%

Jazz Pharmaceuticals

Jazz Pharmaceuticals